Direkt zum Inhalt
Merck
  • Serum lipids and cardiac function correlate with nitrotyrosine and MMP activity in coronary artery disease patients.

Serum lipids and cardiac function correlate with nitrotyrosine and MMP activity in coronary artery disease patients.

European journal of clinical investigation (2015-05-07)
Péter Bencsik, Viktor Sasi, Krisztina Kiss, Krisztina Kupai, Márton Kolossváry, Pál Maurovich-Horvat, Tamás Csont, Imre Ungi, Béla Merkely, Péter Ferdinandy
ZUSAMMENFASSUNG

Peroxynitrite-matrix metalloproteinase (MMP) signalling has been shown to contribute to myocardial ischaemia/reperfusion injury and heart failure and to be influenced by hyperlipidaemia in preclinical models. Therefore, here we investigated the correlation between the markers of peroxynitrite-MMP signalling and hyperlipidaemia in patients with significant coronary stenosis. Five minutes before percutaneous coronary intervention (PCI), arterial blood samples were collected from 36 consecutive patients with coronary artery disease (CAD) selected for elective PCI. Serum nitrotyrosine positively correlated with MMP-9 activity (r = 0·54, P = 0·01), but not with MMP-2 activity. Nitrotyrosine positively correlated with total (r = 0·58; P < 0·01) and LDL cholesterol (r = 0·55; P < 0·01), serum triglyceride (r = 0·47; P < 0·05), and creatinine (r = 0·42; P < 0·05) and negatively correlated with HDL cholesterol (r = -0·46; P < 0·05) and with left ventricular ejection fraction (LVEF; r = -0·55; P < 0·05), respectively. MMP-2 activity correlated positively with total (r = 0·55; P < 0·05) and LDL cholesterol (r = 0·45; P < 0·05). In statin-treated patients, a significantly reduced serum nitrotyrosine was found as compared to statin naives; however, MMP activities and serum cholesterol levels were not different. MMP-9 activity correlated with urea nitrogen (r = 0·42; P < 0·05) and LVEF (r = -0·73; P < 0·01). Serum creatinine correlated negatively with LVEF (r = -0·50, P < 0·01). This is the first demonstration that (i) serum nitrotyrosine correlates with MMP-9 activity, (ii) lipid parameters correlate with nitrotyrosine and MMP-2 activity, (iii) myocardial function correlates with creatinine, nitrotyrosine and MMP-9 activity, and (iv) creatinine correlates with nitrotyrosine and urea nitrogen with MMP-9 activity in patients with CAD. Studying the biomarkers of peroxynitrite-MMP pathway in large prospective trials may reveal their diagnostic avails.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Cholesterin, Sigma Grade, ≥99%
Sigma-Aldrich
Cholesterin, powder, BioReagent, suitable for cell culture, ≥99%
Sigma-Aldrich
Acetylsalicylsäure, ≥99.0%
Sigma-Aldrich
Kreatinin, anhydrous, ≥98%
Sigma-Aldrich
SyntheChol® NS0-Supplement, 500 ×, synthetic cholesterol, animal component-free, sterile-filtered, aqueous solution, suitable for cell culture
Sigma-Aldrich
Essigsäure, suitable for luminescence, BioUltra, ≥99.5% (GC)
Sigma-Aldrich
Aspirin, meets USP testing specifications
Sigma-Aldrich
Cholesterin, from sheep wool, ≥92.5% (GC), powder
Sigma-Aldrich
5α-Androstan-17β-ol-3-on, ≥97.5%
Sigma-Aldrich
Essigsäure, ≥99.5%, FCC, FG
Sigma-Aldrich
Essigsäure, natural, ≥99.5%, FG
Sigma-Aldrich
Acetylsalicylsäure, analytical standard
Sigma-Aldrich
5α-Androstan-17β-ol-3-on, purum, ≥99.0% (TLC)
Sigma-Aldrich
Cholesterin, from lanolin, ≥99.0% (GC)
SAFC
Cholesterin, from sheep wool, Controlled origin, meets USP/NF testing specifications
Sigma-Aldrich
Essigsäure-12C2, 99.9 atom % 12C